Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer

(2009) Katie A. Ashton et al.   GYNECOLOGIC ONCOLOGY

Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic

(2009) V. Polakova et al.   HUMAN MUTATION

TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis

(2009) V Marcel et al.   JOURNAL OF MEDICAL GENETICS

A case–control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression

(2009) Emma De Feo et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Analysis of p53 Gene Polymorphisms and Protein Over-expression in Patients with Breast Cancer

(2009) Mustafa Akkiprik et al.   PATHOLOGY & ONCOLOGY RESEARCH

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent

(2008) Luca Cavallone et al.   BMC CANCER

Importance of TP53 codon 72 and intron 3 duplication 16bppolymorphisms in prediction of susceptibility on breast cancer

(2008) Sandra Costa et al.   BMC CANCER

Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer

(2008) Yuanqing Ye et al.   CANCER

A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients

(2008) A. Woelfelschneider et al.   CARCINOGENESIS

Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment

(2008) Roman Hrstka et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases

(2008) Giovanna De Vecchi et al.   Cancer Detection and Prevention